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hESC colony recovery rateBackground: The therapeutic use of human embryonic stem cells (hESCs) is dependent on an efﬁcient cry-
opreservation protocol for long-term storage. The aim of this study was to determine whether the com-
bination of three cryoprotecting reagents using two freezing systems might improve hESC recovery rates
with maintenance of hESC pluripotency properties for potential cell therapy application.
Methods: Recovery rates of hESC colonies which were frozen in three cryoprotective solutions: Me2SO/
HES/SR medium, Deﬁned-medium and Me2SO/SFB in medium solution were evaluated in ultra-slow
programmable freezing system (USPF) and a slow-rate freezing system (SRF). The hESC pluripotency
properties after freezing-thawing were evaluated.
Results: We estimated the distribution frequency of survival colonies and observed that independent of
the freezing system used (USPF or SRF) the best results were obtained with Me2SO/HES/SR as cryopreser-
vation medium. We showed a signiﬁcant hESC recovery colonies rate after thawing in Me2SO/HES/SR
medium were 3.88 and 2.9 in USPF and SRF, respectively. The recovery colonies rate with Deﬁned-
medium were 1.05 and 1.07 however in classical Me2SO medium were 0.5 and 0.86 in USPF and SRF,
respectively. We showed signiﬁcant difference between Me2SO/HES/SR medium  Deﬁned-medium
and between Me2SO/HES/SR medium Me2SO medium, for two cryopreservation systems (P < 0.05).
Conclusion: We developed an in house protocol using the combination of Me2SO/HES/SR medium and
ultra-slow programmable freezing system which resulted in hESC colonies that remain undifferentiated,
maintain their in vitro and in vivo pluripotency properties and genetic stability. This approach may be
suitable for cell therapy studies.
 2015 Elsevier Inc. All rights reserved.EM/F12,
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Human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSC) have the ability to proliferate indef-
initely in an undifferentiated state, and the ability to differentiate
into multi-lineage cell types of the three germ layers [29,27].
These properties make the hESCs and hiPSCs an attractive source
for potential therapeutic applications, as tools to study human
development, genetic diseases and for transplantation and tissue
regeneration (reviewed in [22]).
A critical requirement for hESC clinical application is to develop
culture protocols that are reproducible, clinically effective and
affordable, and in compliance with quality control and good manu-
factures practice (GMP). The critical factors for clinical application
are to maintain pluripotency, as well as genetic and epigenetic sta-
bility after isolation, propagation, differentiation and cryopreserva-
tion procedures. Regarding to cryopreservation procedures two
relevant aspects in implementing GMP standard are the establish-
ment of the freezing method and cryoprotecting solution [1].
Three methods are used to cryopreserve hESC: slow-rate freez-
ing (SRF, also named conventional cryopreservation method),
ultra-slow programmable freezing (USPF, also named pro-
grammable cryopreservation method) and vitriﬁcation method
[13,17]. The slow-rate cooling is a simple, convenient and less
expensive method compared with the other two methods above
mentioned [6]. However, previous studies using SRF demonstrated
that the recovery of hESC is poor [21,10]. The ultra-slow pro-
grammable freezing requires a controlled rate from 0.3 to
0.6 C/min, which leads to higher cryopreservation efﬁciency
compared with SRF and is in compliance with GMP requirements
although it is relatively expensive [6,13]. The vitriﬁcation method
is suitable for hESC cryopreservation with high efﬁciency recovery
rate. However, the twomain limitations are: (1) the use of the open
pulled strawmethod, with direct hESCs exposure to nitrogen liquid,
which is unsuitable for GMR requirements due the potential for con-
tamination of the sample, and (2) limited ability for large scale cry-
opreservation, because it requires manual picking up of individual
stem cell colonies [1,7].
Another challenge is to combine the cryopreservation method
with cryoprotectant agent, which will result in minor variations
of recovered rate of undifferentiated hESC. The conventional cry-
oprotectant solution used is 10% (v/v) dimethyl sulfoxide
(Me2SO), which is a relatively toxic penetrating cryoprotectant
with low molecular weight, in culture media supplemented with
10–90% (v/v) fetal bovine serum (FBS). However, serum is a com-
plex mixture associated with batch-to-batch variations and may
contain factors that induce hESC differentiation [2,11]. An alterna-
tive to cryopreservation is to combine Me2SO with serum replace-
ment (SR) to improve undifferentiated hESC recovery rate [30].
Also, we test the use of high-molecular cryoprotectant such as
hydroxyethylstarch (HES), which does not penetrate the cells.
HES is a polymeric substance with high molecular weight which
has been explored in combination with Me2SO and has been used
in hESC and in other cell types [28,5,19,30] There is no consensus
about the optimal protocol for cryopreservation hESC [17], espe-
cially about the choice of cryoprotectant combinations, as well
the method of freezing.
Another important aspect of hESC cryopreservation is the size of
the cell clumps. In general, a clump size of about 100–300 cells has
been reported to be optimal for hESC cryopreservation [13]. hESC
detachment has been reported with mechanical slicing or enzy-
matic treatment [21]. One advantage of hESC mechanical slicing
is that it is an animal-free dissociative method and minimize bio-
logical reagent solutions.
To better address this issue in the present study we compared
the recovery rate of undifferentiated hESCs (Me2SO/HES/SR,Deﬁned medium and Me2SO medium) using two freezing methods
(slow-rate freezing and ultra slow programmable freezing). We
demonstrated the high efﬁciency of Me2SO/HES/SR cryopreserva-
tion medium independent of freezing methods. We have devel-
oped an in-house freezing medium for hESCs which maintain
their pluripotency potential, morphology and normal karyotype.
Materials and methods
hESC culture
Human embryonic stem cell lines H1 hESCs (WISC Bank, USA)
were used in this study in accord with the agreement between
the WiCell Research Institute and us (Agreement No.11-W0348).
hESCs were cultured on mitomycin-C inactivated MEF or pre-
coated with Matrigel (BD Biosciences, Franklin Lakes, NJ, USA)
on tissue culture plates at 37 C under 5% CO2. hESCs on MEF were
fed with DMEM/F12 medium supplemented with 20% knockout
serum replacement (SR), 0.5% 2 mM glutamax, 10 mM MEM
nonessential amino acids solution (both from Life Technologies,
NY, NY, USA), 10 ng/mL bFGF (PeproTech, NJ, USA). hESCs on
Matrigel were cultured in mTeSR1 medium (StemCell
Technologies, Vancouver, CA). hESCs cell colonies were picked
out by mechanical disruption using a tip or a cell scraper (Life
Technologies, NY, NY, USA) to give rise to small clumps (100–
300 cells each) and plated on MEF or Matrigel-plate.
Cryopreservation of human hESC
The hESCs were cryopreserved in clumps of 100–300 cells by
using three types of freezing medium and two freezing methods:
slow-rate freezing (SRF) and ultra-slow programmable freezing
(USPF) as shown it experimental design Fig. 1.
The number of adherent hESC colonies cultured in Matrigel
(BD Biosciences, Franklin Lakes, NJ, USA) was counted before freez-
ing. After removing the culture medium, the cells were washed
twice with DMEM/F12 (Invitrogen, NY, NY, USA). Three different
types of freezing media were used for comparative analysis as
described in Table 1.
Slow-rate freezing (SRF)
Speciﬁc freezing medium with hESC clumps were transferred
into a 2 ml cryovial (Greiner Bio One Frickenhausen, Germany).
The cryovials were then immediately placed into a freezing con-
tainer ‘Mr. Frosty’ (Nalgene Nunc, International, Rochester, USA)
containing isopropanol, precooled (2–8 C), and immediately
stored at 80 C. The hESCs were stored in a 80 C freezer over-
night, the cooling rate was about 1 C/min. On the following
day, the cryovial was placed into liquid nitrogen and kept there
for at least 30 days prior to thawing. The hESCs were thawed at
37 C in a water bath with gentle shaking. The thawed samples
were washed with 10 mL of DMEM-F12 medium, centrifuged at
160g for 10 min and hESC pellets were resuspended in 2 mL
mTeSR-1 (StemCell Technologies – Vancouver, CA). The cells were
then placed onto MEF feeder layers and cultured for 7–8 days
(Fig. 1).
Ultra-slow programmable freezing (USPF)
Speciﬁc freezing medium with hESC clumps were transferred
into a 2 ml cryovial (Greiner-Bio One, Frickenhausen, Germany).
The cryovials were then transferred into a controlled-rate freezer
(Freezal, France). Cells were then frozen using USPF method which
proceeds in two steps: ﬁrst the colonies are cooled from +5.0 C to
40 C at a rate of 0.3 C/min and second the colonies are cooled
Fig. 1. Experimental design hESC are cultured under Matrigel. After 7–10 days, hESC are submitted to mechanical dissociation. Next, hESC clump colonies are distributed into
three precooled cryopreservation media and transferred immediately to two freezing methods (SRF and USPF). hESC colonies are kept at liquid nitrogen at least 30 days and
thawing at 37 C. Then, it is evaluated the recovery rate of undifferentiated hESCs and the main hESC characteristics (immunophenotype, embryoid body formation, gene
expression analysis and teratoma formation).
Table 1
Composition freezing media.
Abbreviations Composition media Supply
Me2SO/HES/SR-medium 10% Me2SO
20% HES
70% SR
Me2SO (Sigma, St Louis, MO, USA)
hydroxyethyl starch Voluven 130/04, 6% solution, (Frezenius, Aquiraz-Ceará-Brazil)
70% serum replaced [(SR) – Life Technologies, NY, NY, USA]
Deﬁned-medium Deﬁned cryopreservation medium for hESCs mFreSR-medium – (StemCell Technologies, Vancouver, CA)
Me2SO medium 10% Me2SO
20% SFB
70% DMEM-F12
Me2SO-sigma, St Louis, MO, USA
SFB (Hyclone, Logan, UT, USA)
DMEM/F12 (Life Technologies, NY, NY, USA)
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then plunged into liquid nitrogen for storage and kept there for
at least 30 days prior to thawing. The thawing was performed as
previously described (Fig. 1).
Cryopreservation efﬁciency analysis
The experiments were repeated from ten to sixteen times for
each freezing condition. The cryopreservation efﬁciency was
assessed by the recovery rate of the attached undifferentiated
colonies hESCs evaluated using an inverted phase-contrast
microscope 7–8 days after thawing. The recovery rate is deﬁned
as the ratio of the number of undifferentiated colonies after
thawing to the number of colonies which were present before
freezing. The level of differentiation for each colony was
determined based on morphology. Areas of tight small cells with
high nuclear: cytoplasm ratios were scored as undifferentiated,
and areas with big cells with abundant cytoplasm were scored as
differentiated. The Kolmogorov–Smirnov test was performed to
evaluate signiﬁcant statistical differences. A p < 0.0001 was
considered signiﬁcant.FACS analysis of hESC
hESCs colonies were dissociated by using TrypLE for 10 min and
resuspended in DMEM (both of Life Technologies, NY, NY, USA)
supplemented with 10% SFB (Hyclone, Logan, UT, USA). Nearly,
5  105 cells obtained after freezing /thawing and cultivated for
7 days were labeled with SSEA-3-PE, SSEA-4-PE and their respec-
tive controls (all from BD Pharmingen, San Jose, CA, USA) for
15 min at RT in the dark. For intracellular labeling, cells were ﬁxed
in Fasc Lysing, resuspended in Fasc Permeabilysing II (both from
BD Pharmingen, San Jose, CA, USA) for 10 min, and washed with
PBS. The cells were incubated with anti-SOX-2 and their respective
control (BD-Pharmingen, San Jose, CA, USA) for 15 min at RT.
Following washing the cells were resuspended in FAC buffer and
analyzed on a FACSCaliburTM Cytometer (BD Pharmingen, San
Jose, CA, USA).
Alkaline phosphatase activity detection of hESCs
The hESC colonies were ﬁxed with citrate-acetone-formalde-
hyde solution for 3 min at RT, rinsed twice with Milli-Q H2O and
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St. Louis, MO, USA) according to the manufacturer’s protocol. The
colonies with activity for alkaline phosphatase stained in blue were
analyzed by stereomicroscope and in phase contrast of inverted
microscopes.
hESC differentiation
hESCs were scraped and transferred to ultra-low attachment
dishes (Falcon, Franklin Lakes, NJ, USA) to demonstrate their
spontaneously differentiation into ectodermal, mesodermal and
endodermal lineages by forming embryoid bodies (EB). Cell
colonies were incubated in the StemPro 34 (Life Technologies, NY,
NY, USA) culture medium supplemented with 5% serum
replacement-SR, 0.1 mMnonessential amino acids, 2 mMglutamax,
and 1 of ITS (Life Technologies, NY, NY, USA). After 7 days of culti-
vation, total RNA from EBs was isolated for pluripotency marker
analyses. Some of the EBs were subsequently plated in 24-well
plates (Greiner Bio-One, USA) with coverslip pre-coated with 0.1%
gelatin for 20 min, and grown for a further 8 days in DMEM (Life
Technologies, NY, NY, USA) supplemented with 10% FCS (Hyclone,
Logan, UT, USA). Antigens speciﬁc to ectodermal, mesodermal and
endodermal layer germs were detected by immunostaining.
Immunocytochemistry assay
Colonies originating from frozen-thawed hESCs in Me2SO/HES/
SR-medium (at passage 3 after cryopreservation) were seeded on
glass coverslips (GoldLab, Ribeirão Preto, SP, Brazil) in 24-well
plates (Greiner Bio One, Frickenhausen, Germany) and ﬁxed in 4%
paraformaldehyde (Merck, Whitehouse Station, NJ, USA) for
20 min at room temperature. EBs cells cultured as described above
were ﬁxed with citrate-acetone- formaldehyde solution for 10 min
at RT. Both cells types were washed three times with PBS, incu-
bated with glycine 0.1 M for 30 min and permeabilized with 0.3%
Triton X-100 (Sigma–Aldrich, St. Louis, MO, USA) for 10 min at
room temperature. Then, the cells were treated for 1 h with 1%
bovine serum albumin [(BSA) Sigma–Aldrich, St. Louis, MO, USA]
and 2% goat serum in PBS.
The hESC colonies and EBs were incubated with primary anti-
bodies anti-OCT4 (Chemicon-Millipore, Temecula, CA, USA), anti-
SOX2 (BD Pharmingen, San Diego, CA, USA), anti-Nanog (BD
Pharmingen, San Diego, CA, USA) and anti-SSEA-4 (Chemicon-
Millipore, Temecula, CA, USA) at room temperature for 1 h. The
EBs samples were also incubated with primary antibodies anti-al-
pha-1-fetoprotein (AFP) (A0008, Dako, Glostriup, Denmark,
Europe) and anti-Desmin (DES) (MAB1698) and anti-Nestin (NES)
(both from Chemicon-Millipore, Temecula, CA, USA) at room tem-
perature for 1 h. The secondary antibody used was Alexa Fluor 488
mouse antibody and Alexa Fluor 488 rabbit antibody (both from
Invitrogen, Carlsbad, CA, USA). Nuclei were stained with DAPI
(Vysis, Des Plaines, IL, USA). Cells were observed using a confocal
laser scanning microscope (CLSM) (LSM 710; Carl Zeiss,
OberKochen, Germany). The primary and secondary antibodies
were diluted to 10 lg/mL. The light scattering for each excitation
wavelength was recorded in the multi-tracking mode using sepa-
rate detection channels. Image analysis was carried out using the
ZEN2008 software (Carl Zeiss). Control and test images were cap-
tured using identical settings.
RNA extraction, reverse transcription reaction and RT-PCR
For gene expression analysis of undifferentiated hESC and EB,
total RNA was extracted using the RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions.
First-strand cDNA was synthesized from 1ug RNA using the HighCapacity cDNA Reverse Transcription Kit according to the manu-
facturer’s instructions. For quantitative gene expression analysis
TaqMan assays were performed and analyzed with the 7300 real
time PCR system. The probes used were OCT-4 (Hs00999632_g1),
Nanog (Hs02387400_g1), Sox-2 (Hs01053049_s1). For each run,
all samples were assayed in duplicate. Gene expression was nor-
malized relative by the geometric mean of the endogenous genes
GAPDH (VIC-4326317E), FBXL12 (Hs01556373_a1) and HPRT1
(Hs01003267_m1).
Karyotyping of hESC
The karyotype of hESC was analyzed between passage 3 and 10
after freezing/thaw procedures. Three independents samples of
hESC-H1 were incubated in mTeSR-1 medium containing
0.15 mg/mL colcemid (Sigma–Aldrich, St. Louis, MO, USA) for 3–
4 h, trypsinized, resuspended in KCl-75 mM (Merck, Whitehouse
Station, NJ, USA), incubated at 37 C for 10 min, and ﬁxed in 3:1
methanol: acetic acid (Merck, Whitehouse Station, NJ, USA) at RT
for 10 min. The centrifugation and ﬁxing steps were repeated three
times. The karyotype of 50 metaphases was analyzed using G-
banding method and the results interpreted according to the
International System for Human Cytogenetics Nomenclature
2005 [23]. Additionally, 100 Giemsa-stained metaphases were
screened for chromosome aberrations and other structural abnor-
malities, such as rings and dicentric chromosomes.
Analysis of pluripotency in vivo
The hESC colonies were detached into several small clumps (100
a 150 clumps) by cell scraped (BD Biosciences, Franklin Lakes, NJ,
USA). The clumps were mixed with 700 lL de Matrigel (BD
Biosciences, Franklin Lakes, NJ, USA) and injected subcutaneously
in the back of 4–8-week-old severe combined immunodeﬁcient
(SCID) mice. Eight weeks later, the teratoma was dissected, ﬁxed
in buffered 4% formalin for 24 h and treated with a solution of
30% sucrose for 48 h. The tumor was mounting in freezing media
(OCT, Tissue-Tek, Torrance, CA). 10 lm frozen sections were exam-
ined histologically after hematoxylin and eosin staining.
Statistical analyzes
In order to compare these three media and two freezing
systems a two sided Kolmogorov–Smirnov test was used to check
whether the Me2SO/HES/SR ratios were from the same distribution
as the Deﬁned-medium and Me2SO-medium ratios. A p < 0.0001
was considered signiﬁcant.
For gene expression analysis the Student’s t test was performed
to evaluate signiﬁcant statistical differences using GraphPad
software, version 5.0 (GraphPad Software, San Diego, CA, USA;
www.graphpad.com). We assumed a level of signiﬁcance of
P < 0.05.Results
High efﬁciency of Me2SO/HES/SR cryopreservation solution
independent of freezing methods
First, we analyzed the recovery rate after freezing thawing hESC
in these three media and two freezing systems. As shown in
Table 2, the combination of Me2SO/HES/SR medium and USPF sys-
tem yielded a higher recovery rate than that observed with the
Deﬁned-medium and the Me2SO medium (3.88, 1.05 and 0.5,
respectively). In SRF system, the colony recovery rates were lower
2.9, 1.07, 0.86, respectively. Table II also shows that the number of
Table 2
hECS colonies recovery.
Ultra slow programmable freezing (USPF) system Slow-rate freezing (SRF) cryopreservation system
Me2SO/HES/SR-
medium
Deﬁned-
medium
Me2SO-
medium
Me2SO/HES/SR-
medium
Deﬁned-
medium
Me2SO-
medium
Colony recovery (colonies post – thawing/frozen
colonies)
70/18 (3.88) 18.5/17.5
(1.05)
5/10 (0.5) 119/41 (2.9) 44/41 (1.07) 25/29 (0.86)
Fig. 2. The distribution frequency of the hESC survival colonies compared in different media and cryopreservation systems. A and B with USPF system. C and D with SFR
system. Filled grey: Me2SO/HES/SR medium; ﬁlled narrow stripes: Deﬁned-medium and ﬁlled wide stripes: Me2SO-medium. Undifferentiated hESC survival colony ratios
were statistically evaluated with the Kolmogorov–Smirnov test. A P value of <0.05 was considered signiﬁcant.
M.D. Orellana et al. / Cryobiology 71 (2015) 151–160 155surviving hESCs colonies post-thawing was higher than the num-
ber originally frozen.
In order to compare the recovery rates of hESC colonies in
Me2SO/HES/SR medium using USPF system with Deﬁned-medium,
a two sided Kolmogorov–Smirnov test was used to see whether the
Me2SO/HES/SR medium ratios were from the same frequency dis-
tribution of hESC survival colonies as the Deﬁned-medium ratios.
Using a signiﬁcance level of 0.05, the null was rejected (p < 0.0001)
(Fig 2A). Comparing the results of Me2SO/HES/SR medium and
Me2SO-medium the null was again rejected p < 0.0001 (Fig 2B).
These suggest that the differences of distribution frequencies
of hESC survival colonies are signiﬁcant in USPF system and
media dependent. We also compare the Me2SO/HES/SR medium
in SFR system with Deﬁned-medium using a two side
Kolmogorov–Smirnov test as mentioned above. Again, using a sig-
niﬁcance level of 0.05, the null was rejected (p < 0.0001) (Fig 2C).
Comparing the results of Me2SO/HES/SR medium and Me2SO-
medium the null was also rejected with p < 0.0001 (Fig 2D). Alltogether, these results suggest that using ultra-slow programma-
ble system, the hESC recovery ratios are higher in the house
Me2SO/HES/SR medium compared with the other two media. The
same is observed for slow cooling rate system.
Considering that the USPF system showed higher hESC colony
recovery rates compared to SRF system in the three media, we
continue our analysis using only the USPF system.
Morphology and quantitative analysis of hESC colonies in Me2SO/HES/
SR cryopreservation medium compared with two other cryoprotecting
media
We ﬁrst analyzed the morphology of hESC colonies at 30 min.
and 7 days post-thawing. Thirty minutes after thawing we
observed higher number of hESC clumps of approximately
100–300 cells in Me2SO/HES/SR medium (Fig. 3A) compared with
Deﬁned-medium (Fig. 3B). As regards the Me2SO-medium, the
morphology analysis shows that most hESC clumps failed to attach
Fig. 3. Morphology and quantitative analysis of hESC colonies in Me2SO/HES/SR cryopreservation medium compared with two other cryoprotecting media. hESC clumps
morphology 30 min after thawing (Fig. 2A–C). Morphological analysis of undifferentiated hESC colonies 7–8 days after thawing (Fig. 2D–F). Analyzed in inverted phase
contrast microscopes, scale bars represents 200 lm. Alkaline phosphatase activity analyzed in stereomicroscope 15 days after thawing (Fig. 2G–I). A, D and G-Me2SO/HES/SR
medium; B, E and H Deﬁned-medium; C, F and I Me2SO medium.
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(Fig. 3C). To investigate the presence of undifferentiated hESC colo-
nies we performed the analysis after 7 days. In Me2SO/HES/SR and
Deﬁned-media hESC colonies were successfully maintained in
undifferentiated state (Fig. 3 D and E). The same was not observed
in Me2SO-medium (Fig. 3F).
We also evaluated the number of hESC survival colonies after
alkaline phosphatase (AP) staining to obtain the colony formation
efﬁciency. We observed that colony formation efﬁciency was high
in Me2SO/HES/SR medium (Fig. 3G), in Deﬁned-medium (Fig. 3H)
and low in Me2SO-medium (Fig. 3I).
In vitro post-thaw characterization of hESCs
To conﬁrm that the cryopreserved hESCs maintain the charac-
teristics of pluripotent hESC we analyzed the hESC colony mor-
phology and several markers by ﬂow cytometry and
immunostaining. hESC colonies maintained the typical hESC mor-
phology of compact colonies with distinct borders (Fig. 4A) and
showed alkaline phosphatase activity (Fig. 4B). Additionally,
immunostaining for OCT-4, Nanog-4, Sox-2 and SSEA-4 were pos-
itive as showed at Fig. 4C–F. For quantitative evaluation of pluripo-
tent identity, ﬂow cytometry analysis was carried antigen cell-
surfaces. The analyses showed that hESCs reacted positively to
SOX-2 (70.3%), SSEA3 (70.1%) and SSEA4 (57.1%) (Fig. 4G–I).
The in vitro differentiation potential of hESC post-thaw into
three germ layers was analyzed by embryoid bodies (EB)formation. The morphological analysis showed EBs simple round
structure as well as cystic form (Fig. 5A). We observe that these
EBs can further differentiate into endoderm (a-fetoprotein, AFP),
mesoderm (Desmin) and ectoderm (Nestin) (Fig. 5B–D) detected
by immunocytochemistry.
Also, gene expression analyses of undifferentiated hESC colo-
nies and embryoid bodies showed that undifferentiated hESCs
express the pluripotency markers OCT4, NANOG, SOX-2 and
SSEA-4. As expected, in EBs the expression pattern of OCT4 and
NANOG EBs were down-regulated.
We also performed the karyotype of hESC between three and
ten passages post-thaw. We showed that hESC frozen/thawed
after three passages maintain the normal karyotype of 46
chromosomes indicating karyotypic stability of hESC after
Me2SO/HES/SR freeze–thaw protocol described in this article
(Fig. 5F). The karyotype after the tenth passage (not shown) was
also normal.
In vivo post-thaw characterization of hESCs
The in vivo differentiation potential of cryopreserved cells after
thawing was examined by the ability to generate teratomas in
NOD/SCID mice. Histological analysis of teratomas revealed that
hESCs kept their ability of differentiating into three cell germ lay-
ers, including cartilage, muscle, glandular epithelium and primitive
neural tissue (Fig. 6). These data suggest that hESC cryopreserved
in Me2SO/HES/SR using USPF system retain pluripotency capacity.
Fig. 4. The colonies analyses after freezing/thawing in USPF system with Me2SO/HES/SR medium. A – Analyzed in phase contrast of inverted microscopes scale bars represent
100 lm. B – Alkaline Phosphatase activity scale bars represent 500 lm. C–F – Immunoﬂuorescence marking, C: OCT-4, D: NANOG, E: SOX-2 and F: SSEA-4, scale bars
represent 100 lm. G–I – Flow cytometry analysis, G: SOX-2, H: SSEA-3 and I: SSEA-4.
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Fig. 5. In vitro analysis of pluripotency properties. A – Embryoid bodies (EB) analyzed at phase contrast of inverted microscope scale bars represent 200 lm;
B–D – Immunoﬂuorescence of AFP; Desmin and Nestin, respectively – scale bars represents 10 lm. E – Gene expression analysis of NANOG, OCT-4 and SOX-2 by real time PCR
from hESC colonies and embryonic bodies after freezing/thawing in DMOS/HES/SR medium at USPF system. The Student’s t distribution was performed to evaluate signiﬁcant
statistical differences we assumed a level of signiﬁcance of P < 0.05. Statistically signiﬁcant differences are denoted by an asterisk. F – Cytogenetic analyses of hESC colonies
cryopreserved in Me2SO/HES/SR medium. Normal karyotypes were detected in hESCs three passages after thawing.
Fig. 6. In vivo analyses of pluripotency capacity. Teratoma formation from hESC colonies cryopreserved in Me2SO/HES/SR ten passages after thawing. A – Three germ layers
were identiﬁed (400 fold); B – The presence of mesoderm tissues (cartilage, and muscles, 1.000 fold); C – Endoderm tissue (gland-like tissue) and D – Ectoderm tissue (neural
rosettes). Hematoxylin and eosin histological staining.
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In this study, we report the use of an in house freezing solution
together with mechanical scraping for ultra-slow programmable
freezing of hESC. Our experiments have shown that the highest
hESC recovery rate was observed with the use of Me2SO/HES/SR
as cryopreservation solution and ultra-slow programmable freez-
ing system. In general, hESC cryopreservation has the following
steps: (a) harvesting hESC colonies; (b) addition of cryoprotective
agents within a protein-rich medium (serum or replacement
serum); (c) cryopreservation at a controlled rate (from 0.3 to
10.0 C/min. or 1.0 C/min.); (d) storage at cryogenic tempera-
tures (usually in liquid nitrogen); (e) rapid thawing at 37oC water
bath; (f) removal of cryoprotective agent and (g) hESC culture at
designed medium [17].
We observed that the number of hESC colonies post-thaw
increased compared with the initial number. This increase can be
attributed to the use of mechanical scraping for hESC colony
detachment. To better investigate the variations of hESC recovery
rates with three cryopreservation media we estimated the distri-
bution frequency of survival colonies in each assay (Fig. 2). We
observed that independently of the freezing system used (USPF
or SRF) the best results were obtained with Me2SO/HES/SR as the
cryopreservation solution. Also, the comparison of hESC recovery
rate using Me2SO/HES/SR medium or Me2SO-medium was much
higher and signiﬁcantly different in both USPF and SRF systems
(p < 0.0001 and p < 0.0001, respectively).
The most common component of cryopreservation medium
for slow cooling system is the low-molecular weight cryoprotec-
tant agent known as dimethylsulfoxide (Me2SO) [12]. This
component is able to penetrate the cellular membrane and per-
meate the cells, which reduces the formation of intra-cellular
ice crystals. The main technical problems with this cryopreserva-
tion approach is that the inner regions of hESC clumps may not
fully be exposed to Me2SO. As consequence, it resulted in a low
recovery rate, atypical clump size and differentiated hESC colo-
nies as observed in this study with Me2SO-medium, which had
recovery rates of 0.5 and 0.86 in both USPF and SRF, respectively.
To overcome this limitation, previous studies have been reported
using the combination of high-molecular weight cryoprotectant
with Me2SO. Examples of high-molecular weight cryoprotectant
are: dextran, hydroxyethyl starch, polyvinyl-pyrrolidone, and
polyvinyl-alcohol [30,4]. These types of cryoprotectants remain
in the extracellular space where they form a shell around
the cells. Also, they contribute to membrane stabilization and
cell dehydration, thus minimizing intracellular ice crystal
formation [25].
Among these high-molecular weight cryopreservation agents,
our group has previously reported the successfully recovery of
umbilical cord mesenchymal cells using the solution composed
of 70% human serum, 10% Me2SO and 20% hydroxyethyl starch
[20]. The combination of HES with Me2SO has been used for other
cell types as red blood cells [15,24], granulocytes [14], cultured
hamster cells [3], pancreatic islets [9,18], bone marrow and blood
stem cells [16,26] and others. In some of these protocols a third
cryoprotecting agent has been used [25]. Up to now, there is no
consensus about the best protocol for hESC cryopreservation using
HES and Me2SO. A good recovery rate was obtained by the combi-
nation of 5% Me2SO/5% HES/20% SR [30,17]. As mentioned previ-
ously the advantage of SR it that it contains deﬁned components
that reduce the experimental variability associated with serum
batch variations [2].
Also, while we were written this manuscript Imaizumi et al. [8]
reported a good hESC recovery rate by the combination of 5%
Me2SO and 6% HES and using 4% ethylene glycol instead replace-
ment serum. However, in this protocol the authors used anenzymatic approach for hESC colony detachment and therefore
the results are not comparable.
We also evaluated the efﬁcacy of our protocol for hESC cryop-
reservation by characterizing hESC colonies after freezing and
thawing. We demonstrated that hESC cryopreserved using in house
HES/Me2SO/SR medium and ultra-slow programmable freezing
system resulted in hESC colonies that remain undifferentiated,
maintain their in vitro and in vivo pluripotency properties and
genetic stability.
This study reveals an approach to obtain efﬁcient hESC recovery
rates under good-manufacturing practices (GMP), with low costs,
easily performed in many laboratory settings, may allow scalable
hESC cryopreservation and can be used for cell therapy protocols.
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